Development and validation of the Vitiligo Extent Score for a Target Area (VESTA) to assess the treatment response of a target lesion.

measurement outcome target lesion treatment response validation vitiligo

Journal

Pigment cell & melanoma research
ISSN: 1755-148X
Titre abrégé: Pigment Cell Melanoma Res
Pays: England
ID NLM: 101318927

Informations de publication

Date de publication:
03 2019
Historique:
received: 29 05 2018
revised: 09 07 2018
accepted: 24 07 2018
pubmed: 18 8 2018
medline: 9 8 2019
entrez: 18 8 2018
Statut: ppublish

Résumé

Since localized treatment for vitiligo is as essential as systemic treatment, a reliable instrument for target evaluation is needed besides those for whole body evaluation. We developed the Vitiligo Extent Score for a Target Area (VESTA) using reference images of both marginal and perifollicular repigmentation to measure the repigmentation rate (%) in a target lesion. In the validation study, a total of 65 dermatologists in 10 institutes evaluated 17 pairs of vitiligo images (pre- and post-treatment) using both a rough estimate and the VESTA. The VESTA (concordance correlation coefficient: 0.949, 95% confidence interval [CI] 0.942-0.955) was significantly more accurate than the rough estimate (0.896, 95% CI: 0.883-0.908). It was also associated with better inter-rater reliability over the rough estimate, albeit not significant. The VESTA can afford intuitive, convenient, and reliable assessment of the treatment response in a target area, and would be useful in clinical practice as well as retrospective studies.

Identifiants

pubmed: 30117287
doi: 10.1111/pcmr.12730
doi:

Types de publication

Journal Article

Langues

eng

Pagination

315-319

Informations de copyright

© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Jung Min Bae (JM)

Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Sang Ho Oh (SH)

Department of Dermatology, Yonsei University College of Medicine, Seoul, Korea.

Hee Young Kang (HY)

Department of Dermatology, Ajou University Hospital School of Medicine, Suwon, Korea.

Young Wook Ryoo (YW)

Department of Dermatology, School of Medicine, Keimyung University, Daegu, Korea.

Cheng-Che E Lan (CE)

Department of Dermatology, Kaohsiung Medical University Hospital, and College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Lei-Hong Xiang (LH)

Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.

Ki-Ho Kim (KH)

Department of Dermatology, Dong-A University School of Medicine, Busan, Korea.

Tamio Suzuki (T)

Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan.

Ichiro Katayama (I)

Department of Pigmentation Research and Therapeutics, Graduate School of Medicine, Osaka City University, Osaka, Japan.

Seung-Chul Lee (SC)

Department of Dermatology, Chonnam National University School of Medicine, Gwangju, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH